Dihydergot 2.5mg Tablets Australia - engleză - Department of Health (Therapeutic Goods Administration)

dihydergot 2.5mg tablets

novartis pharmaceuticals australia pty ltd - dihydroergotamine mesylate - tablets - 2.5mg - antimigraine preparations

SPORANOX ORAL SOLUTION Israel - engleză - Ministry of Health

sporanox oral solution

j-c health care ltd - itraconazole - solution - itraconazole 10 mg/ml - itraconazole - itraconazole - sporanox oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. prevention of fungal infection during neutropenia of immunodeficient patients.

Norvir Tablets 100 mg Singapore - engleză - HSA (Health Sciences Authority)

norvir tablets 100 mg

abbvie pte. ltd. - ritonavir - tablet, film coated - 100.0 mg - ritonavir 100.0 mg

Klacid 250mg Film-Coated Tablets Malta - engleză - Medicines Authority

klacid 250mg film-coated tablets

abbott laboratories limited - clarithromycin 250 mg - film-coated tablet

Klacid 500mg Film-Coated Tablets Malta - engleză - Medicines Authority

klacid 500mg film-coated tablets

abbott laboratories limited - clarithromycin 500 mg - film-coated tablet

Klacid XL 500mg Modified-Release Tablets Malta - engleză - Medicines Authority

klacid xl 500mg modified-release tablets

abbott laboratories limited - clarithromycin 500 mg - modified-release tablet

Vicks Sinex Decongestant Nasal Spray Malta - engleză - Medicines Authority

vicks sinex decongestant nasal spray

procter & gamble (health & beauty care) limited the heights brooklands, weybridge, surrey kt13 0xp, united kingdom - oxymetazoline - nasal spray, solution - oxymetazoline 0.05 % (w/v) - nasal preparations

Vfend Uniunea Europeană - engleză - EMA (European Medicines Agency)

vfend

pfizer europe ma eeig - voriconazole - candidiasis; mycoses; aspergillosis - antimycotics for systemic use - voriconazole, is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows:treatment of invasive aspergillosis;treatment of in candidaemianon-neutropenic patients;treatment of fluconazole-resistant serious invasive candida infections (including c. krusei);treatment of serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to patients with progressive, possibly life-threatening infections.prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.

EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle Australia - engleză - Department of Health (Therapeutic Goods Administration)

evotaz atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle

bristol-myers squibb australia pty ltd - cobicistat, quantity: 150 mg; atazanavir, quantity: 300 mg - tablet, film coated - excipient ingredients: stearic acid; croscarmellose sodium; hyprolose; crospovidone; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide red - evotaz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.